BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 8591034)

  • 1. The crystal structure of cyclin A.
    Brown NR; Noble ME; Endicott JA; Garman EF; Wakatsuki S; Mitchell E; Rasmussen B; Hunt T; Johnson LN
    Structure; 1995 Nov; 3(11):1235-47. PubMed ID: 8591034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystal structure of a viral cyclin, a positive regulator of cyclin-dependent kinase 6.
    Schulze-Gahmen U; Jung JU; Kim SH
    Structure; 1999 Mar; 7(3):245-54. PubMed ID: 10368294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bound to activate: conformational consequences of cyclin binding to CDK2.
    Radzio-Andzelm E; Lew J; Taylor S
    Structure; 1995 Nov; 3(11):1135-41. PubMed ID: 8591024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of p21Cip1/Waf1 peptide domains required for cyclin E/Cdk2 and PCNA interaction.
    Chen IT; Akamatsu M; Smith ML; Lung FD; Duba D; Roller PP; Fornace AJ; O'Connor PM
    Oncogene; 1996 Feb; 12(3):595-607. PubMed ID: 8637717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The structural basis for specificity of substrate and recruitment peptides for cyclin-dependent kinases.
    Brown NR; Noble ME; Endicott JA; Johnson LN
    Nat Cell Biol; 1999 Nov; 1(7):438-43. PubMed ID: 10559988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIRA, the human homologue of yeast Hir1p and Hir2p, is a novel cyclin-cdk2 substrate whose expression blocks S-phase progression.
    Hall C; Nelson DM; Ye X; Baker K; DeCaprio JA; Seeholzer S; Lipinski M; Adams PD
    Mol Cell Biol; 2001 Mar; 21(5):1854-65. PubMed ID: 11238922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of CDK activation revealed by the structure of a cyclinA-CDK2 complex.
    Jeffrey PD; Russo AA; Polyak K; Gibbs E; Hurwitz J; Massagué J; Pavletich NP
    Nature; 1995 Jul; 376(6538):313-20. PubMed ID: 7630397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The structure of cyclin H: common mode of kinase activation and specific features.
    Andersen G; Busso D; Poterszman A; Hwang JR; Wurtz JM; Ripp R; Thierry JC; Egly JM; Moras D
    EMBO J; 1997 Mar; 16(5):958-67. PubMed ID: 9118957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crystal structure of the p27Kip1 cyclin-dependent-kinase inhibitor bound to the cyclin A-Cdk2 complex.
    Russo AA; Jeffrey PD; Patten AK; Massagué J; Pavletich NP
    Nature; 1996 Jul; 382(6589):325-31. PubMed ID: 8684460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secondary structure prediction and unrefined tertiary structure prediction for cyclin A, B, and D.
    Gerloff DL; Cohen FE
    Proteins; 1996 Jan; 24(1):18-34. PubMed ID: 8628731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Helical fold prediction for the cyclin box.
    Bazan JF
    Proteins; 1996 Jan; 24(1):1-17. PubMed ID: 8628726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cyclin box fold: protein recognition in cell-cycle and transcription control.
    Noble ME; Endicott JA; Brown NR; Johnson LN
    Trends Biochem Sci; 1997 Dec; 22(12):482-7. PubMed ID: 9433129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specificity determinants of recruitment peptides bound to phospho-CDK2/cyclin A.
    Lowe ED; Tews I; Cheng KY; Brown NR; Gul S; Noble ME; Gamblin SJ; Johnson LN
    Biochemistry; 2002 Dec; 41(52):15625-34. PubMed ID: 12501191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclin B and cyclin A confer different substrate recognition properties on CDK2.
    Brown NR; Lowe ED; Petri E; Skamnaki V; Antrobus R; Johnson LN
    Cell Cycle; 2007 Jun; 6(11):1350-9. PubMed ID: 17495531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystal structure of a gamma-herpesvirus cyclin-cdk complex.
    Card GL; Knowles P; Laman H; Jones N; McDonald NQ
    EMBO J; 2000 Jun; 19(12):2877-88. PubMed ID: 10856233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crystal structure of the retinoblastoma tumor suppressor protein bound to E2F and the molecular basis of its regulation.
    Xiao B; Spencer J; Clements A; Ali-Khan N; Mittnacht S; Broceño C; Burghammer M; Perrakis A; Marmorstein R; Gamblin SJ
    Proc Natl Acad Sci U S A; 2003 Mar; 100(5):2363-8. PubMed ID: 12598654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structuring cell-cycle biology.
    Levine K; Cross FR
    Structure; 1995 Nov; 3(11):1131-4. PubMed ID: 8591023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The C-terminal regulatory domain of p53 contains a functional docking site for cyclin A.
    Luciani MG; Hutchins JR; Zheleva D; Hupp TR
    J Mol Biol; 2000 Jul; 300(3):503-18. PubMed ID: 10884347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three-dimensional structure of human cyclin H, a positive regulator of the CDK-activating kinase.
    Kim KK; Chamberlin HM; Morgan DO; Kim SH
    Nat Struct Biol; 1996 Oct; 3(10):849-55. PubMed ID: 8836101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The consensus motif for phosphorylation by cyclin D1-Cdk4 is different from that for phosphorylation by cyclin A/E-Cdk2.
    Kitagawa M; Higashi H; Jung HK; Suzuki-Takahashi I; Ikeda M; Tamai K; Kato J; Segawa K; Yoshida E; Nishimura S; Taya Y
    EMBO J; 1996 Dec; 15(24):7060-9. PubMed ID: 9003781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.